Drug and Therapeutics Bulletin

Drug and Therapeutics Bulletin

The Drug and Therapeutics Bulletin is a monthly journal that offers scientific assessments and practical guidance on specific treatments and the management of various diseases. It is published by the BMJ Group and remains completely independent from industry, government, and regulatory bodies. The journal does not include display advertisements or accept any type of commercial sponsorship.

Trade/B2B
English
Magazine

Outlet metrics

Domain Authority
92
Ranking

Global

N/A

Country

N/A

Category

N/A

Traffic sources
Monthly visitors

Articles

  • 1 month ago | dtb.bmj.com | David Phizackerley |BMJ Journals

    Drug-Related Side Effects and Adverse Reactions Health Care Quality, Access, and Evaluation A recent article published in the BMJ argued that a polypill containing various commonly prescribed cardiovascular medicines should be offered as primary prevention to all people in the UK over the age of 50 years to reduce the risk of heart attacks and strokes.1 The paper, based on discussions at a ‘consensus building seminar’ held in London in 2024, claimed that the introduction of a cardiovascular...

  • Mar 1, 2025 | dtb.bmj.com | David Phizackerley |BMJ Journals

    Drug-Related Side Effects and Adverse Reactions Health Care Quality, Access, and Evaluation In January 2025, an article published in The Lancet assessed the population-health impact of medicines that had been approved by the National Institute for Health and Care Excellence (NICE) between 2000 and 2020.1 Huseyin Naci and colleagues calculated a net health benefit from each new medicine and the estimated effect that theoretically could be obtained by using the money spent on those medicines...

  • Jan 27, 2025 | dtb.bmj.com | Michael Wilcock |David Phizackerley |BMJ Journals

    Drug-Related Side Effects and Adverse ReactionsHealth Care Quality, Access, and EvaluationThe importance of patient-centred care and the active engagement and involvement of patients in decisions about their own healthcare have long been recognised.1 For some treatment decisions, the best option may be obvious, but for many others, especially for preventative treatments, there can be several choices open to the patient.

  • Dec 4, 2024 | dtb.bmj.com | Joanna Owens |Teck K Khong

    Adverse effects of antihypertensives in frail older people Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Sep 6, 2024 | dtb.bmj.com | David Phizackerley |BMJ Journals

    Supporting the treatment of obesity Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Drug and Therapeutics Bulletin journalists